相关实验视频
Updated: Jul 12, 2025
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
表皮状肉瘤的转化方面:当前的共识
Thomas G P Grünewald1,2,3,4, Sophie Postel-Vinay5,6, Robert T Nakayama7
1Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
概括
表皮状肉瘤 (EpS) 是一种罕见的癌症,结果不佳. 迫切需要新的向疗法,因为目前的治疗方法,如tazemetostat对大多数患者的成功是有限的.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 表皮状肉瘤 (EpS) 是一种极为罕见的软组织癌症,主要影响年轻人.
- 尽管采取了激进的多式疗法,但EPS的预后很差,死亡率约为50%.
- 由于SMARCB1基因被删除而导致INI1表达的丧失是EPS亚型的特征.
研究的目的:
- 从翻译研究的角度回顾目前对EPS的理解.
- 确定用于EPS诊断和治疗的创新研究方向.
- 通过专家共识和患者倡导来解决由专家共识和患者倡导定义的关键问题.
主要方法:
- 从国际EPS会议 (2021,2023) 中的文献审查和专家共识.
- 分析当前的治疗策略及其局限性.
- 识别EPS生物学和治疗方面的知识差距.
主要成果:
- 一种EZH2抑制剂Tazemetostat是第一个被批准用于EPS的向疗法,但对少数患者有益.
- 免疫疗法和其他新型治疗方法仅在一小部分EPS病例中表现出有效性.
- 对于有效的,针对EPS的诊断工具和疗法,存在重大未满足的需求.
结论:
- 迫切需要新的,针对EPS的治疗策略.
- 加快翻译研究对于开发新疗法至关重要.
- 研究人员,临床医生和患者团体之间的持续合作对于推进EPS护理至关重要.
相关概念视频
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
02:33Initiation of Translation
33.8K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
33.8K